Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5397
-0.0556 %
$ 23 M
Market Cap
-3.17
P/E
ADAP - CASH & EQUIVALENTS
Cash & Equivalents ADAP - Adaptimmune Therapeutics plc
144 M
LAST VALUE
-2.01%
2 YEAR CAGR
16.06%
5 YEAR CAGR
88.98%
10 YEAR CAGR